Media
Press Releases
October 22, 2026
Auchincloss, Griffith Introduce Faster Clinical Trials Act
FOR IMMEDIATE RELEASECONTACT: Georgina.Burros@mail.house.gov (Auchincloss) AUCHINCLOSS, GRIFFITH INTRODUCE FASTER CLINICAL TRIALS ACT WASHINGTON, D.C. — Today, Reps. Jake Auchincloss (D-MA) and Morgan Griffith (R-VA) released the Faster Clinical Trials Act. The proposal would speed the development of new treatments, invest in clinical research, and propel U.S. leadership in biomedical innovation. For decades, the United States has led the world in biomedical research and development; the test… Continue Reading
October 16, 2026Auchincloss, Amo, Balint Conduct Unannounced Oversight Visit to Burlington ICE Facility
FOR IMMEDIATE RELEASE CONTACT: Georgina.Burros@mail.house.gov The Burlington, Massachusetts U.S. Immigration and Customs Enforcement (ICE) facility serves as the New England regional headquarters and field office. Burlington, MA - TODAY, Jake Auchincloss (D-MA-04), Congressman Gabe Amo (D-RI-01), and Congresswoman Becca Balint (D-VT-AL) conducted an unannounced congressional oversight visit to the Burlington Immigration and Customs Enforcement (ICE) facility. This site is a short-term facilit… Continue Reading
September 15, 2026Reps. Auchincloss, Houchin Introduce Bipartisan 16 & Up Social Media Act to Keep Kids Under 16 Off Addictive Social Media Platforms
FOR IMMEDIATE RELEASE Contact: Georgina.Burros@mail.house.gov (Auchincloss) Washington, D.C. — Congressman Jake Auchincloss (D-MA) and Congresswoman Erin Houchin (R-IN), co-chairs of the bipartisan Kids Online Safety Caucus, introduced the 16 & Up Social Media Act to establish a national age standard of 16 for social media platforms. Social media companies are the merchants and miners of digital dopamine, spending hundreds of billions of dollars annually to manipulate, monetize, and atten… Continue Reading
In The News
October 30, 2026
Auchincloss bill seeks to improve ‘operating system for science’
For more than a decade, it has been clear that U.S. clinical trials are too slow, too costly, and too far removed from the places where patients get care. It has taken the success of competitors, especially in China, and the outflow of Phase I trials to Australia, to move policymakers toward action. Fear of falling behind has created a nonpartisan constituency for modernizing clinical trials infrastructure. The need to reauthorize FDA user fees by Oct. 1, 2027 has provided a vehicle and a deadl… Continue Reading
October 22, 2026New bipartisan bill aims to speed up clinical trials for rare disease treatments
One week after the Food and Drug Administration unveiled a new initiative for speeding up the approval of rare diseases treatments, new legislation is being introduced to reimagine the way that those drugs are studied. The bipartisan bill, which will be introduced today by Democratic Rep. Jake Auchincloss and Republican Rep. Morgan Griffith, would make it easier for more patients to participate in clinical trials and reduce the time it takes to get them started. The so-called “Faster Clinical T… Continue Reading
October 15, 2026Mass. lawmaker Auchincloss favors boosting U.S. biotech over targeting China
Rep. Jake Auchincloss (D-Mass.) has some advice for fellow lawmakers: unapologetically support the biotech industry, vilify insurance companies, and focus on making America a biotech research haven, instead of relying on protectionism. Right now in Washington, it’s popular to support protectionist policies against China in industries like tech. China is rapidly gaining on the U.S. biotechnology industry, and there is bipartisan support to extend those protections to the biotech sector. Auchinc… Continue Reading